Items where Author is "on behalf of the VERTIS-CV, Investigators"

Cannon, Christopher P. and McGuire, Darren K. and Pratley, Richard and Dagogo-Jack, Sam and Mancuso, James and Huyck, Susan and Charbonnel, Bernard and Shih, Weichung J. and Gallo, Silvina and Masiukiewicz, Urszula and Golm, Gregory and Cosentino, Francesco and Lauring, Brett and Terra, Steven G. and on behalf of the VERTIS-CV, Investigators and Ukraine: and Godlevska, Olga and Chopey, Ivan and Teliatnikova, Zinaida and Kuskalo, Petro and Abrahamovych, Orest and Mankovskyi, Borys and Fushtey, Ivan and Myshanych, Galyna and Tykhonova, Susanna and Tseluyko, Vira and Koval, Olena and Parkhomenko, Oleksandr and Prokhorov, Oleksandr and Vayda, Myroslava and Martymianova, Larysa and Zharinova, Viktoriia and Prystupa, Lyudmyla and Pererva, Larysa and Kovalov, Oleksandr and Sokolova, Lyubov and Botsyurko, Volodymyr and Maslyanko, Vitaliy and Vlasenko, Maryna and Khomazyuk, Tetyana and Kulyk, Anna and Synenko, Volodymyr and Karpenko, Oleksandr and Mostovoy, Yuriy and Gyrina, Olga and Dolzhenko, Maryna and Donets, Oleksandra and Sorokina, Inna and Malynovsky, Yaroslav and Lysunets, Olena and Petrovskyy, Roman and Panina, Svitlana (2018) Design and baseline characteristics of the eValuation of ERTugliflozin effIcacy and Safety CardioVascular outcomes trial (VERTIS-CV). American Heart Journal, 206. pp. 11-23. ISSN 0002-8703 (Print), 1097-6744 (Online)